Award
NIH Reporter #5R21CA286417-02
Development of adverse event (AE) derived biomarkers for predicting clinical outcomes in lung cancer
Recipient
H. LEE MOFFITT CANCER CTR & RES INST
Award Amount
$236,321.00
Ceiling
$236,321.00
Awarded
December 16, 2024
Identifier
5R21CA286417-02
Award for developing biomarkers from adverse events to predict clinical outcomes in lung cancer, aiming to enhance precision medicine through innovative tools and data analysis.
Description
This highly translational study aims to change the paradigm of AE data usage from descriptive summary into modern informative AE biomarkers to fulfill precision medicine. The project focuses on developing biomarkers for adverse events (AEs) to predict clinical outcomes in lung cancer, utilizing innovative analysis tools and comprehensive data strategies.